Armata Pharmaceuticals, Inc. Ratios

Ratios Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -15,576.54%5,650.12%-506.74%-7,459.23%-12,295.65%1,648.77%2,092.27%-11,377.95%-546.80%-670.24%-2,277.30%955.06%
EBIT Margin -15,288.89%-3,449.88%-2,153.05%-8,991.54%-14,048.70%1,743.14%2,121.59%-11,070.26%-544.63%-670.77%-2,148.71%762.14%
EBITDA Margin -71,119.75%-3,449.88%-2,153.05%-8,991.54%-14,048.70%1,648.08%2,092.27%-11,070.26%-544.63%-670.77%-2,148.71%762.14%
Operating Margin -15,288.89%-3,449.88%-2,153.05%-8,991.54%-14,048.70%1,743.14%2,121.59%-11,070.26%-544.63%-670.77%-2,148.71%762.14%
Net Margin -80,495.06%3,852.57%-2,272.42%-9,336.92%-12,488.70%1,648.77%2,193.02%-11,374.87%-546.80%-670.24%-2,277.30%955.06%
FCF Margin -7,893.83%-3,367.73%-2,103.37%-4,186.54%-8,043.48%1,135.44%1,697.74%-9,791.79%-568.79%-629.85%-2,919.97%708.15%
Efficiency
Assets Average 34.91M30.05M24.82M14.65M
Equity Average -9.59M8.08M11.22M8.73M
Invested Capital -22.62M3.44M12.71M9.72M7.73M
Asset Utilization Ratio 0.010.020.010.01
Leverage & Solvency
Interest Coverage Ratio -53.15-33.86-42.20-0.00M-17.43-21.22-34.37-238.22-15.57-3.95
Equity Ratio -0.550.120.400.540.69
Times Interest Earned -53.15-33.86-42.20-0.00M-17.43-21.22-34.37-238.22-15.57-3.95
Dividends & Payouts
FCF Payout Ratio -0.01
Valuation
Enterprise Value 80.04M71.24M14.05M-0.24M4.46M6.78M32.29M55.82M148.43M44.82M117.11M66.94M
Market Capitalization 100.40M77.83M23.42M4.89M9.59M6.78M32.29M55.82M148.43M44.82M117.11M66.94M
Return Ratios
Return on Sales -155.77%56.50%-4.91%-72.45%-111.63%16.16%20.92%-113.78%-5.47%-6.70%-22.77%9.55%
Return on Capital Employed -0.43%-0.37%-1.10%-1.27%
Return on Invested Capital -1.23%-2.02%-1.68%
Return on Assets 0.66%-0.08%-0.76%-0.88%
Return on Equity -2.41%-0.29%-1.68%-1.47%